Alfuzosin EP Impurity F
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

19216-53-6Alfuzosin EP Impurity F

● Auf Lager

Katalog-Nr.::VL259005
CAS-Nr.::19216-53-6
Summenformel::C12H16N4O2
Molare Masse::248.28 g/mol

Zusätzliche Informationen zu CAS 19216-53-6

Parent drug

Alfuzosin

IUPAC-Name

6, 7-dimethoxy-N2, N2-dimethylquinazoline-2, 4-diamine

Pharmakopöe-Synonyme

N/A

Other Synonyms

2,4-Quinazolinediamine, 6,7-dimethoxy-N2,N2-dimethyl

Smile

NC1=C2C=C(OC)C(OC)=CC2=NC(N(C)C)=N1

InChI

InChI=1S/C12H16N4O2/c1-16(2)12-14-8-6-10(18-4)9(17-3)5-7(8)11(13)15-12/h5-6H,1-4H3,(H2,13,14,15)

Beschreibung

Alfuzosin EP Impurity F is a meticulously characterized reference material that complies with rigorous regulatory requirements, including those defined by USP, EMA, JP, and BP. This product plays a crucial role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of 2,4-Quinazolinediamine, 6,7-dimethoxy-N2,N2-dimethyl. It is further supported by a detailed Structure Elucidation Report (SER), ensuring high accuracy and reliability across a broad range of analytical applications. Alfuzosin EP Impurity F (cas no.-19216-53-6) IUPAC Name-6,7-dimethoxy-N2, N2-dimethylquinazoline-2,4-diamine; Molecular Formula- C12H16N4O2; Molecular weight-248.28; Alfuzosin EP Impurity F is an impurity of Alfuzosin. Alfuzosin is used in the treatment of benign prostatic hyperplasia. It’s a quinazoline derivative, it antagonizes a1-adrenoceptor selectively and competitively leading to contraction of the prostatic, prostatic capsule, bladder base, and proximal urethral smooth muscle, thereby re

References

Wilde, Michelle I., et al. “Alfuzosin.” Drugs, vol. 45, no. 3, Mar. 1993, pp. 410–29, https://doi.org/10.2165/00003495-199345030-00008.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url